{
    "nctId": "NCT02798484",
    "briefTitle": "Monitoring of Breast Cancers Treated by Neoadjuvant Therapy Via Diffusion-weighted Magnetic Resonance Imaging",
    "officialTitle": "Pilot Study: Monitoring of Breast Cancers Treated by Neoadjuvant Therapy Via Diffusion-weighted Magnetic Resonance Imaging",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 61,
    "primaryOutcomeMeasure": "Apparent diffusion coefficient (ADC) (mm2/sec)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast cancer\n* Neo-adjuvant therapy indication\n* Performance status from 0 to 2\n\nExclusion Criteria:\n\n* Contraindications to magnetic resonance imaging (pacemaker, nerve stimulator, cochlear implant, major claustrophobia)\n* Absence of histological results\n* Disruption of the neo-adjuvant therapy",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}